BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

resverlogix Pages on BioPortfolio:

Biotechnology News alzheimer rvx. resverlogix. apoa. beta40 ...
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Resverlogix Corporation - Profile
View the current Resverlogix Corporation Page on BioPortfolio.com ... Resverlogix advances to second arm of Phase 1b/2a clinical trial ...
http://www.bioportfolio.com/biocorporate/29213-Resverlogix+C...

Biotechnology News alzheimer rvx. beta40. apoa. 208. hdl. sparkss ...
Resverlogix Corp. announced that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebeta-HDL elevating drug, in a post-hoc analysis from the ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - BioPortfolio - Resverlogix Corporation
BioPortfolio - Resverlogix Corporation - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/29213/www.r...

Biotechnology News alzheimer avid. adni. amyloid. av. 18f ...
Resverlogix Corp. announced that treatment with its lead drug RVX-208, a first in class ... ('Resverlogix') announced today that treatment with its. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - resverlogix
Resverlogix Corporation - Entry on Bioportfolio's Biocorporate Database. ... Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial Pharma Live:
...
http://www.bioportfolio.com/search/resverlogix.html...

Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial
Pharma Live:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - Biocorporate Search Calgary
Resverlogix Corporation Resverlogix Corporation is a publicly traded biotechnology company (RVX: TSX) focused on ... www.resverlogix.com/ View full
profile ...
http://www.bioportfolio.com/biocorporate/search/city/Calgary...

Biotechnology News alzheimer 11cpib. cognit. roe. patholog ...
10 /PRNewswire-FirstCall/ - Resverlogix Corp. ('Resverlogix') announced today that treatment with its... KOTA Territory News: Nov 10 2008 11:58PM ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology News alzheimer boustani. malaz. schubert. wishard ...
10 Nov 2008 ... 10 /PRNewswire-FirstCall/ - Resverlogix Corp. ('Resverlogix') announced today that treatment with its lead. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Results from other life science and pharmaceutical sites:

BioSpace - Resverlogix Corporation News, Search Jobs, Events
Company Profile. Resverlogix Corporation #202, 279 Midpark Way SE Calgary T2X 1M2 Canada Phone: 403-254-9252 Fax: 403-256-8495 ...
http://www.biospace.com/company_profile.aspx?CompanyId=68532...

Resverlogix Announces Closing of Debt Redemption
("Resverlogix") (TSX:RVX) announced today that the Toronto Stock Exchange has approved Resverlogix's previous announcement on October 15, 2008 regarding the
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

Resverlogix Announces Closing of Debt Redemption: Financial News ...
Resverlogix Announces Closing of Debt Redemption. - TSX Exchange Symbol: RVX CALGARY, Oct. 17 /CNW/ - Resverlogix Corp. (Resverlogix) (TSX:RVX - News) ...
http://biz.yahoo.com/cnw/081017/resverlogix_redemptn.html?.v...

Resverlogix Corporation Advances to Second Arm of Phase 1b/2a ...
("Resverlogix") announced today that the ongoing double blind placebo controlled Phase 1b/2a study in subjects with normal and low HDL is progressing as ...
http://www.biospace.com/news_story.aspx?NewsEntityId=113808...

Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial ...
TSX Exchange Symbol: RVX CALGARY, Oct. 21 /CNW/ - Resverlogix Corp. (Resverlogix ) (TSX:RVX - News) announced today that the ongoing double blind placebo ...
http://biz.yahoo.com/cnw/081021/resverlogixclncltrial.html?....

BioPortfolio - Resverlogix Corporation - Profile
View the current Resverlogix Corporation Page on BioPortfolio.com ... Resverlogix advances to second arm of Phase 1b/2a clinical trial ...
http://www.bioportfolio.com/biocorporate/29213-Resverlogix+C...

News: Resverlogix Initiates Alzheimer's Research Program. Genetic ...
Resverlogix Initiates Alzheimer's Research Program. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business.
http://www.genengnews.com/news/bnitem.aspx?name=13778022...

Jan Gray Joins Resverlogix Corporation Board of Di - News ...
("Resverlogix" or the "Company") is pleased to announce effective immediately Jan Gray, CA has joined the Company's Board of Directors. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=104810...

BioPortfolio - BioPortfolio - Resverlogix Corporation
BioPortfolio - Resverlogix Corporation - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/29213/www.r...

Resverlogix Corporation Reverse Cholesterol Transport by RVX-208 a ...
6 Nov 2007 ... 5 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") is pleased to announce today key scientific data was presented in an oral ...
http://www.biospace.com/news_story.aspx?NewsEntityId=76383...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.